Labcorp Holdings (LH) EBITDA Margin (2009 - 2026)

Labcorp Holdings has disclosed EBITDA Margin across 18 years of filings, most recently posting 12.1% for Q2 2026.

• In Q2 2026, EBITDA Margin rose 92.0% year-over-year to 12.1%; the TTM figure through Jun 2026 stood at 10.43% (up 160.0% YoY), while the FY2025 annual figure was 9.92%, up 157.0% from the prior year.
• EBITDA Margin came in at 12.1% for Q2 2026 at Labcorp Holdings, up from 10.76% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 17.64% in Q1 2022 to a low of 4.05% in Q4 2023.
• Average EBITDA Margin over 5 years is 9.23%, with a median of 9.93% recorded in 2024.
• Year-over-year, EBITDA Margin sank 4754 bps in 2022 and surged 1055 bps in 2024.
• Over 5 years, EBITDA Margin stood at 0.97% in 2022, then sank by 516 bps to 4.05% in 2023, then soared by 261 bps to 6.5% in 2024, then climbed by 17 bps to 7.61% in 2025, then surged by 59 bps to 12.1% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 12.1% in Q2 2026, 10.76% in Q1 2026, and 7.61% in Q4 2025.